Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus
•MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state. Piperine has been shown to have antioxidant act...
Gespeichert in:
Veröffentlicht in: | Behavioural brain research 2018-01, Vol.337, p.131-138 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 138 |
---|---|
container_issue | |
container_start_page | 131 |
container_title | Behavioural brain research |
container_volume | 337 |
creator | Khalili-Fomeshi, Mohsen Azizi, Mohammad Golparvar Esmaeili, Mohammad Reza Gol, Mohammad Kazemi, Sohrab Ashrafpour, Manouchehr Moghadamnia, Ali Akbar Hosseinzadeh, Soheila |
description | •MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state.
Piperine has been shown to have antioxidant activity and a cognitive-enhancing effect following long-term oral administration. In a comparative study of memantine, the current investigation threw light on the cognitive benefits of piperine. Lipid peroxidation and the ferric reducing antioxidant power (FRAP) of cerebrospinal fluid (CSF) and hippocampus in streptozotocin (STZ)-induced experimental dementia of the Alzheimer’s type was measured. After reaching a criterion in a memory test, STZ-induced rats received piperine [2.5, 5, and 10mg/kg, intraperitoneally (i.p.)], vehicle, and memantine (10mg/kg, i.p.) for two weeks after the first STZ administration, or two weeks before and one week after, as a preventive approach. After the behavioral studies, samples were taken for biochemical and histological assays. An appropriate concentration of piperine (2.5mg/kg), on a daily basis, effectively increased the number of correct (non-repeated) arm entries and repressed reentry to a previously visited arm, in terms of reference errors as well as memantine (10mg/kg, i.p.), irrespective of the dose administered. The cognitive-enhancing effect induced by piperine at a relevant dose was simultaneous with CSF and hippocampal malonaldehyde decrement, and the redox balance was established to some extent by maintaining the FRAP levels of CSF near to those of the control. Similarly, the neuroprotective properties of piperine are in accordance with histopathological outcomes, which have shown an increased number of live cresyl violet (CV)-positive neurons in a dentate gyrus (DG) subregion. Therefore, the effects of piperine on the redox balance of CSF and hippocampal neurons may certainly contribute to the cognitive-enhancing activity of the drug. |
doi_str_mv | 10.1016/j.bbr.2017.09.031 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1942700132</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166432817310938</els_id><sourcerecordid>1942700132</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-661da8cd69d32c17b22d10933b93851e5a9bed1c2687db67490800086a1f4ba43</originalsourceid><addsrcrecordid>eNp9kLtuFTEQhi1ERA6BB6BBLml28WVvhgpFXCJFCgXUli9zkjnatRfbGwEPkOeOwwmUNDPNN7_m_wh5xVnLGR_eHlprUysYH1umWib5E7Lj0yiase_UU7KrzNB0Ukyn5HnOB8ZYx3r-jJyKSUnVMbkjd19xhYQBaIJcYh00lwRrib9jiQ5Dg8FvDjx18TpgwVuguKwG0wKh5Hf0ImS8vimZYiiRxp_ozR_ImtkEV-FAHSSwKeYVg5npft7QUxM8vcF1jc4s65ZfkJO9mTO8fNxn5Punj9_OvzSXV58vzj9cNk72sjTDwL2ZnB-Ul8Lx0QrhOVNSWiWnnkNvlAXPnRim0dth7BSbautpMHzfWdPJM_LmmLum-GOrjfWC2cFcf4W4Zc1VJ0bGuBQV5UfU1ddzgr1eEy4m_dKc6Qf9-qCrfv2gXzOlq_568_oxfrML-H8Xf31X4P0RgFryFiHp7BCqJ48JXNE-4n_i7wG_H5jc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1942700132</pqid></control><display><type>article</type><title>Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Khalili-Fomeshi, Mohsen ; Azizi, Mohammad Golparvar ; Esmaeili, Mohammad Reza ; Gol, Mohammad ; Kazemi, Sohrab ; Ashrafpour, Manouchehr ; Moghadamnia, Ali Akbar ; Hosseinzadeh, Soheila</creator><creatorcontrib>Khalili-Fomeshi, Mohsen ; Azizi, Mohammad Golparvar ; Esmaeili, Mohammad Reza ; Gol, Mohammad ; Kazemi, Sohrab ; Ashrafpour, Manouchehr ; Moghadamnia, Ali Akbar ; Hosseinzadeh, Soheila</creatorcontrib><description>•MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state.
Piperine has been shown to have antioxidant activity and a cognitive-enhancing effect following long-term oral administration. In a comparative study of memantine, the current investigation threw light on the cognitive benefits of piperine. Lipid peroxidation and the ferric reducing antioxidant power (FRAP) of cerebrospinal fluid (CSF) and hippocampus in streptozotocin (STZ)-induced experimental dementia of the Alzheimer’s type was measured. After reaching a criterion in a memory test, STZ-induced rats received piperine [2.5, 5, and 10mg/kg, intraperitoneally (i.p.)], vehicle, and memantine (10mg/kg, i.p.) for two weeks after the first STZ administration, or two weeks before and one week after, as a preventive approach. After the behavioral studies, samples were taken for biochemical and histological assays. An appropriate concentration of piperine (2.5mg/kg), on a daily basis, effectively increased the number of correct (non-repeated) arm entries and repressed reentry to a previously visited arm, in terms of reference errors as well as memantine (10mg/kg, i.p.), irrespective of the dose administered. The cognitive-enhancing effect induced by piperine at a relevant dose was simultaneous with CSF and hippocampal malonaldehyde decrement, and the redox balance was established to some extent by maintaining the FRAP levels of CSF near to those of the control. Similarly, the neuroprotective properties of piperine are in accordance with histopathological outcomes, which have shown an increased number of live cresyl violet (CV)-positive neurons in a dentate gyrus (DG) subregion. Therefore, the effects of piperine on the redox balance of CSF and hippocampal neurons may certainly contribute to the cognitive-enhancing activity of the drug.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/j.bbr.2017.09.031</identifier><identifier>PMID: 28939403</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Alkaloids - therapeutic use ; Alzheimer’s disease ; Analysis of Variance ; Animals ; Antibiotics, Antineoplastic - toxicity ; Avoidance Learning - drug effects ; Benzodioxoles - therapeutic use ; Cerebrospinal fluid ; Cognition Disorders - cerebrospinal fluid ; Cognition Disorders - chemically induced ; Cognition Disorders - drug therapy ; Cognition Disorders - pathology ; Cognitive impairment ; Cytochrome P-450 Enzyme Inhibitors - therapeutic use ; Dose-Response Relationship, Drug ; Hippocampus - drug effects ; Hippocampus - metabolism ; Hippocampus - pathology ; Lipid Peroxidation - drug effects ; Male ; Malondialdehyde - cerebrospinal fluid ; Maze Learning - drug effects ; Memantine - cerebrospinal fluid ; Memory, Short-Term - drug effects ; Neurons - drug effects ; Neurons - pathology ; Oxidative stress ; Piperidines - therapeutic use ; Piperine ; Polyunsaturated Alkamides - therapeutic use ; Rats ; Rats, Wistar ; Streptozocin - toxicity ; Streptozotocin</subject><ispartof>Behavioural brain research, 2018-01, Vol.337, p.131-138</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-661da8cd69d32c17b22d10933b93851e5a9bed1c2687db67490800086a1f4ba43</citedby><cites>FETCH-LOGICAL-c353t-661da8cd69d32c17b22d10933b93851e5a9bed1c2687db67490800086a1f4ba43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbr.2017.09.031$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28939403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khalili-Fomeshi, Mohsen</creatorcontrib><creatorcontrib>Azizi, Mohammad Golparvar</creatorcontrib><creatorcontrib>Esmaeili, Mohammad Reza</creatorcontrib><creatorcontrib>Gol, Mohammad</creatorcontrib><creatorcontrib>Kazemi, Sohrab</creatorcontrib><creatorcontrib>Ashrafpour, Manouchehr</creatorcontrib><creatorcontrib>Moghadamnia, Ali Akbar</creatorcontrib><creatorcontrib>Hosseinzadeh, Soheila</creatorcontrib><title>Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus</title><title>Behavioural brain research</title><addtitle>Behav Brain Res</addtitle><description>•MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state.
Piperine has been shown to have antioxidant activity and a cognitive-enhancing effect following long-term oral administration. In a comparative study of memantine, the current investigation threw light on the cognitive benefits of piperine. Lipid peroxidation and the ferric reducing antioxidant power (FRAP) of cerebrospinal fluid (CSF) and hippocampus in streptozotocin (STZ)-induced experimental dementia of the Alzheimer’s type was measured. After reaching a criterion in a memory test, STZ-induced rats received piperine [2.5, 5, and 10mg/kg, intraperitoneally (i.p.)], vehicle, and memantine (10mg/kg, i.p.) for two weeks after the first STZ administration, or two weeks before and one week after, as a preventive approach. After the behavioral studies, samples were taken for biochemical and histological assays. An appropriate concentration of piperine (2.5mg/kg), on a daily basis, effectively increased the number of correct (non-repeated) arm entries and repressed reentry to a previously visited arm, in terms of reference errors as well as memantine (10mg/kg, i.p.), irrespective of the dose administered. The cognitive-enhancing effect induced by piperine at a relevant dose was simultaneous with CSF and hippocampal malonaldehyde decrement, and the redox balance was established to some extent by maintaining the FRAP levels of CSF near to those of the control. Similarly, the neuroprotective properties of piperine are in accordance with histopathological outcomes, which have shown an increased number of live cresyl violet (CV)-positive neurons in a dentate gyrus (DG) subregion. Therefore, the effects of piperine on the redox balance of CSF and hippocampal neurons may certainly contribute to the cognitive-enhancing activity of the drug.</description><subject>Alkaloids - therapeutic use</subject><subject>Alzheimer’s disease</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Antibiotics, Antineoplastic - toxicity</subject><subject>Avoidance Learning - drug effects</subject><subject>Benzodioxoles - therapeutic use</subject><subject>Cerebrospinal fluid</subject><subject>Cognition Disorders - cerebrospinal fluid</subject><subject>Cognition Disorders - chemically induced</subject><subject>Cognition Disorders - drug therapy</subject><subject>Cognition Disorders - pathology</subject><subject>Cognitive impairment</subject><subject>Cytochrome P-450 Enzyme Inhibitors - therapeutic use</subject><subject>Dose-Response Relationship, Drug</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Hippocampus - pathology</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Male</subject><subject>Malondialdehyde - cerebrospinal fluid</subject><subject>Maze Learning - drug effects</subject><subject>Memantine - cerebrospinal fluid</subject><subject>Memory, Short-Term - drug effects</subject><subject>Neurons - drug effects</subject><subject>Neurons - pathology</subject><subject>Oxidative stress</subject><subject>Piperidines - therapeutic use</subject><subject>Piperine</subject><subject>Polyunsaturated Alkamides - therapeutic use</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Streptozocin - toxicity</subject><subject>Streptozotocin</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLtuFTEQhi1ERA6BB6BBLml28WVvhgpFXCJFCgXUli9zkjnatRfbGwEPkOeOwwmUNDPNN7_m_wh5xVnLGR_eHlprUysYH1umWib5E7Lj0yiase_UU7KrzNB0Ukyn5HnOB8ZYx3r-jJyKSUnVMbkjd19xhYQBaIJcYh00lwRrib9jiQ5Dg8FvDjx18TpgwVuguKwG0wKh5Hf0ImS8vimZYiiRxp_ozR_ImtkEV-FAHSSwKeYVg5npft7QUxM8vcF1jc4s65ZfkJO9mTO8fNxn5Punj9_OvzSXV58vzj9cNk72sjTDwL2ZnB-Ul8Lx0QrhOVNSWiWnnkNvlAXPnRim0dth7BSbautpMHzfWdPJM_LmmLum-GOrjfWC2cFcf4W4Zc1VJ0bGuBQV5UfU1ddzgr1eEy4m_dKc6Qf9-qCrfv2gXzOlq_568_oxfrML-H8Xf31X4P0RgFryFiHp7BCqJ48JXNE-4n_i7wG_H5jc</recordid><startdate>20180130</startdate><enddate>20180130</enddate><creator>Khalili-Fomeshi, Mohsen</creator><creator>Azizi, Mohammad Golparvar</creator><creator>Esmaeili, Mohammad Reza</creator><creator>Gol, Mohammad</creator><creator>Kazemi, Sohrab</creator><creator>Ashrafpour, Manouchehr</creator><creator>Moghadamnia, Ali Akbar</creator><creator>Hosseinzadeh, Soheila</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180130</creationdate><title>Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus</title><author>Khalili-Fomeshi, Mohsen ; Azizi, Mohammad Golparvar ; Esmaeili, Mohammad Reza ; Gol, Mohammad ; Kazemi, Sohrab ; Ashrafpour, Manouchehr ; Moghadamnia, Ali Akbar ; Hosseinzadeh, Soheila</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-661da8cd69d32c17b22d10933b93851e5a9bed1c2687db67490800086a1f4ba43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Alkaloids - therapeutic use</topic><topic>Alzheimer’s disease</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Antibiotics, Antineoplastic - toxicity</topic><topic>Avoidance Learning - drug effects</topic><topic>Benzodioxoles - therapeutic use</topic><topic>Cerebrospinal fluid</topic><topic>Cognition Disorders - cerebrospinal fluid</topic><topic>Cognition Disorders - chemically induced</topic><topic>Cognition Disorders - drug therapy</topic><topic>Cognition Disorders - pathology</topic><topic>Cognitive impairment</topic><topic>Cytochrome P-450 Enzyme Inhibitors - therapeutic use</topic><topic>Dose-Response Relationship, Drug</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Hippocampus - pathology</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Male</topic><topic>Malondialdehyde - cerebrospinal fluid</topic><topic>Maze Learning - drug effects</topic><topic>Memantine - cerebrospinal fluid</topic><topic>Memory, Short-Term - drug effects</topic><topic>Neurons - drug effects</topic><topic>Neurons - pathology</topic><topic>Oxidative stress</topic><topic>Piperidines - therapeutic use</topic><topic>Piperine</topic><topic>Polyunsaturated Alkamides - therapeutic use</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Streptozocin - toxicity</topic><topic>Streptozotocin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khalili-Fomeshi, Mohsen</creatorcontrib><creatorcontrib>Azizi, Mohammad Golparvar</creatorcontrib><creatorcontrib>Esmaeili, Mohammad Reza</creatorcontrib><creatorcontrib>Gol, Mohammad</creatorcontrib><creatorcontrib>Kazemi, Sohrab</creatorcontrib><creatorcontrib>Ashrafpour, Manouchehr</creatorcontrib><creatorcontrib>Moghadamnia, Ali Akbar</creatorcontrib><creatorcontrib>Hosseinzadeh, Soheila</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khalili-Fomeshi, Mohsen</au><au>Azizi, Mohammad Golparvar</au><au>Esmaeili, Mohammad Reza</au><au>Gol, Mohammad</au><au>Kazemi, Sohrab</au><au>Ashrafpour, Manouchehr</au><au>Moghadamnia, Ali Akbar</au><au>Hosseinzadeh, Soheila</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus</atitle><jtitle>Behavioural brain research</jtitle><addtitle>Behav Brain Res</addtitle><date>2018-01-30</date><risdate>2018</risdate><volume>337</volume><spage>131</spage><epage>138</epage><pages>131-138</pages><issn>0166-4328</issn><eissn>1872-7549</eissn><abstract>•MDA and FRAP levels of CSF and hippocampus were evaluated in STZ-induced rats.•Anti-oxidant power, neuron survival, and cognition of hippocampus correlated positively.•CSF redox balance relationship with hippocampus, underline a neuroprotective state.
Piperine has been shown to have antioxidant activity and a cognitive-enhancing effect following long-term oral administration. In a comparative study of memantine, the current investigation threw light on the cognitive benefits of piperine. Lipid peroxidation and the ferric reducing antioxidant power (FRAP) of cerebrospinal fluid (CSF) and hippocampus in streptozotocin (STZ)-induced experimental dementia of the Alzheimer’s type was measured. After reaching a criterion in a memory test, STZ-induced rats received piperine [2.5, 5, and 10mg/kg, intraperitoneally (i.p.)], vehicle, and memantine (10mg/kg, i.p.) for two weeks after the first STZ administration, or two weeks before and one week after, as a preventive approach. After the behavioral studies, samples were taken for biochemical and histological assays. An appropriate concentration of piperine (2.5mg/kg), on a daily basis, effectively increased the number of correct (non-repeated) arm entries and repressed reentry to a previously visited arm, in terms of reference errors as well as memantine (10mg/kg, i.p.), irrespective of the dose administered. The cognitive-enhancing effect induced by piperine at a relevant dose was simultaneous with CSF and hippocampal malonaldehyde decrement, and the redox balance was established to some extent by maintaining the FRAP levels of CSF near to those of the control. Similarly, the neuroprotective properties of piperine are in accordance with histopathological outcomes, which have shown an increased number of live cresyl violet (CV)-positive neurons in a dentate gyrus (DG) subregion. Therefore, the effects of piperine on the redox balance of CSF and hippocampal neurons may certainly contribute to the cognitive-enhancing activity of the drug.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28939403</pmid><doi>10.1016/j.bbr.2017.09.031</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0166-4328 |
ispartof | Behavioural brain research, 2018-01, Vol.337, p.131-138 |
issn | 0166-4328 1872-7549 |
language | eng |
recordid | cdi_proquest_miscellaneous_1942700132 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Alkaloids - therapeutic use Alzheimer’s disease Analysis of Variance Animals Antibiotics, Antineoplastic - toxicity Avoidance Learning - drug effects Benzodioxoles - therapeutic use Cerebrospinal fluid Cognition Disorders - cerebrospinal fluid Cognition Disorders - chemically induced Cognition Disorders - drug therapy Cognition Disorders - pathology Cognitive impairment Cytochrome P-450 Enzyme Inhibitors - therapeutic use Dose-Response Relationship, Drug Hippocampus - drug effects Hippocampus - metabolism Hippocampus - pathology Lipid Peroxidation - drug effects Male Malondialdehyde - cerebrospinal fluid Maze Learning - drug effects Memantine - cerebrospinal fluid Memory, Short-Term - drug effects Neurons - drug effects Neurons - pathology Oxidative stress Piperidines - therapeutic use Piperine Polyunsaturated Alkamides - therapeutic use Rats Rats, Wistar Streptozocin - toxicity Streptozotocin |
title | Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A05%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Piperine%20restores%20streptozotocin-induced%20cognitive%20impairments:%20Insights%20into%20oxidative%20balance%20in%20cerebrospinal%20fluid%20and%20hippocampus&rft.jtitle=Behavioural%20brain%20research&rft.au=Khalili-Fomeshi,%20Mohsen&rft.date=2018-01-30&rft.volume=337&rft.spage=131&rft.epage=138&rft.pages=131-138&rft.issn=0166-4328&rft.eissn=1872-7549&rft_id=info:doi/10.1016/j.bbr.2017.09.031&rft_dat=%3Cproquest_cross%3E1942700132%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1942700132&rft_id=info:pmid/28939403&rft_els_id=S0166432817310938&rfr_iscdi=true |